Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and IILinnea Thorlacius, Gregor B. E. Jemec, Amit Garg et al.|British Journal of Dermatology|2017Cited by 40
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical PracticeNicole Mastacouris, Amit Garg, Rachel Tannenbaum et al.|JAMA Dermatology|2023Cited by 18
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis SuppurativaAmit Garg, John R. Ingram, Andrew Strunk et al.|JAMA Dermatology|2025Cited by 4
729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitisMelinda Gooderham, David Rosmarin, Maxwell Sauder et al.|British Journal of Dermatology|2024Cited by 2